Atlas FDA

LEGOO ENDOVASCULAR OCCLUSION GEL

FDA premarket approval P110003/S002 · decided 2012-11-13

Approval details

PMA number
P110003
Supplement
S002
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
LEGOO ENDOVASCULAR OCCLUSION GEL
Generic name
Occluder, internal vessel, temporary
Applicant
Genzyme Corp.
Date received
2012-10-15
Decision date
2012-11-13
Days to decision
29 days
Decision code
OK30
Product code
OBC
Advisory committee
Cardiovascular
Expedited review
No
Location
Cambridge, MA
Statement
CHANGES TO THE PACKAGING CONFIGURATIONS OF THE DEVICE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OSOM INFLUENZA A&B TEST (K061508)Genzyme Corp.2006-06-12
GENZYME OSOM INFLUENZA A & B TEST (K051244)Genzyme Corp.2006-02-21
N-GENEOUS WIDE RANGE CRP REAGENT AND CALIBRATOR SET (K040241)Genzyme Corp.2004-06-25
SEPRAMESH IP BIORESORBABLE BARRIER - PERMANENT MESH (K040868)Genzyme Corp.2004-06-04
GENZYME OSOM TRICHOMONAS RAPID TEST (K033864)Genzyme Corp.2004-04-02
GENZYME CONTRAST II HCG URINE/SERUM TEST (K023544)Genzyme Corp.2003-01-16
ULTRA N-GENEOUS HDL CHOLESTEROL REAGENT 1/REAGENT2; ULTRA N-GENEOUS HDL CHOLESTREOL CALIBRATOR (K021316)Genzyme Corp.2002-07-25
COTTONY II, SILKY II POLYDEK & TEVDEK II POLYESTER SUTURE (K021019)Genzyme Corp.2002-06-18